MedCity News July 27, 2021
The hedge fund SS&C Technologies Holdings will be the majority stakeholder, while the two payers will each hold a minority interest in the PBM, dubbed DomaniRx. The joint venture will develop a claims adjudication platform to support its operations.
Anthem and Humana have entered into a joint venture with hedge fund and private equity administrator SS&C Technologies Holdings to create DomaniRx, a pharmacy benefit manager.
SS&C Technologies holds an 80.2% interest in the joint venture, while Louisville, Kentucky-based Humana and Indianapolis-based Anthem each hold a minority interest.
The joint venture will develop a cloud-native, application programming interface-driven claims adjudication platform to support its operations. DomaniRx will be a full-service pharmacy benefits manager, which are companies that manage prescription drug benefits...
Today's Sponsors
Today's Sponsor